Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 2
1995 1
1996 2
1997 1
1999 2
2000 2
2001 5
2002 2
2003 2
2004 5
2005 5
2006 6
2007 8
2008 9
2009 12
2010 6
2011 7
2012 8
2013 9
2014 10
2015 11
2016 9
2017 13
2018 7
2019 10
2020 10
2021 3
2022 7
2023 9
2024 7
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic Cancer.
Nichetti F, Silvestri M, Agnelli L, Franza A, Pircher C, Rota S, Ambrosini P, Fotia G, Hüllein J, Randon G, Lajer P, Perrone F, Tamborini E, Leoncini G, Coppa J, Busset MDD, Pusceddu S, Milione M, Morano F, Pietrantonio F, Pruneri G, Mazzaferro V, Lipka DB, Köhler BC, Hübschmann D, Fröhling S, de Braud F, Niger M. Nichetti F, et al. Among authors: tamborini e. Cancer Med. 2024 Dec;13(23):e70393. doi: 10.1002/cam4.70393. Cancer Med. 2024. PMID: 39618336 Free PMC article.
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial.
Nasca V, Prinzi N, Coppa J, Prisciandaro M, Oldani S, Ghelardi F, Conca E, Capone I, Busico A, Perrone F, Tamborini E, Sabella G, Greco G, Greco FG, Tafuto S, Procopio G, Morano F, Niger M, Maccauro M, Milione M, de Braud F, Pietrantonio F, Pusceddu S. Nasca V, et al. Among authors: tamborini e. Eur J Cancer. 2024 Sep;209:114276. doi: 10.1016/j.ejca.2024.114276. Epub 2024 Aug 9. Eur J Cancer. 2024. PMID: 39128186 Clinical Trial.
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.
Lorenzini D, Gaudioso G, Scardoni A, Blandi L, Del Gobbo A, Rafaniello Raviele P, Ferrero S, Veronese SM, Lauricella C, Pagni F, Seminati D, Miozzo M, Pesenti C, Gianelli U, Buiatiotis S, Fumagalli C, Guerini Rocco E, Rappa A, Barberis M, Fusco N, Ranghiero A, La Rosa S, Sessa F, Furlan D, Sahnane N, Patriarca C, Cangi MG, Lume A, Doglioni C, Ponzoni M, Vermi W, Novali M, Paulli M, Boveri E, Terracciano L, Uccella S, Destro A, Tamborini E, Perrone F, Pasotti F, Agustoni F, De Braud F, Grossi F, Siena S, Curigliano G, Buoro S, Pruneri G. Lorenzini D, et al. Among authors: tamborini e. Tumori. 2025 Aug;111(4):293-301. doi: 10.1177/03008916251341996. Epub 2025 Jul 10. Tumori. 2025. PMID: 40637305 Free PMC article.
Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?
Azzollini J, Capone I, Duca M, Vingiani A, Piccolo A, Agnelli L, Tamborini E, Perrone F, Peissel B, Lorenzini D, Damian S, Vernieri C, Bianchi GV, Mantiero M, Ducceschi M, Polignano M, Niger M, Nichetti F, Proto C, Brambilla M, Colombo E, Stellato M, Conca E, Busico A, Manoukian S. Azzollini J, et al. Among authors: tamborini e. Tumori. 2024 Dec 9:3008916241280127. doi: 10.1177/03008916241280127. Online ahead of print. Tumori. 2024. PMID: 39311051
Targeted therapies: the rare cancer paradigm.
Pierotti MA, Negri T, Tamborini E, Perrone F, Pricl S, Pilotti S. Pierotti MA, et al. Among authors: tamborini e. Mol Oncol. 2010 Feb;4(1):19-37. doi: 10.1016/j.molonc.2009.10.003. Epub 2009 Oct 28. Mol Oncol. 2010. PMID: 19913465 Free PMC article. Review.
Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues.
Busico A, Gasparini P, Rausa E, Cattaneo L, Bozzi F, Silvestri M, Capone I, Conca E, Tamborini E, Perrone F, Vitellaro M, Ricci MT, Casanova M, Chiaravalli S, Bergamaschi L, Massimino M, Milione M, Sozzi G, Pruneri G, Ferrari A, Signoroni S. Busico A, et al. Among authors: tamborini e. Sci Rep. 2024 Jun 7;14(1):13138. doi: 10.1038/s41598-024-64149-7. Sci Rep. 2024. PMID: 38849509 Free PMC article.
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.
Nichetti F, Brambilla M, Duca M, Piccolo A, Miliziano D, Cavalli C, Marra F, Ambrosini P, Zanella C, Vernieri C, Lorenzini D, Colombo E, Damian S, Baili P, Proto C, Busico A, Conca E, Capone I, Manoukian S, Tamborini E, Perrone F, Niger M, Vingiani A, Agnelli L, de Braud F, Pruneri G. Nichetti F, et al. Among authors: tamborini e. JCO Precis Oncol. 2025 Jun;9:e2400387. doi: 10.1200/PO-24-00387. Epub 2025 Jun 11. JCO Precis Oncol. 2025. PMID: 40499091 Free PMC article.
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Cavalieri S, Platini F, Bergamini C, Resteghini C, Galbiati D, Bossi P, Perrone F, Tamborini E, Quattrone P, Licitra L, Locati LD, Alfieri S. Cavalieri S, et al. Among authors: tamborini e. Expert Opin Investig Drugs. 2019 May;28(5):435-443. doi: 10.1080/13543784.2019.1598376. Epub 2019 Apr 4. Expert Opin Investig Drugs. 2019. PMID: 30897975 Free article. Review.
Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.
Conca E, Lorenzini D, Minna E, Agnelli L, Duca M, Gentili M, Bodini B, Polignano M, Mantiero M, Damian S, Devecchi A, Dagrada G, Carminati R, Ardore A, Barbetta F, Da Chuna NB, Guerrizio A, Busico A, Capone I, Piccolo A, Tamborini E, Perrone F, Milione M, Paolini B, Vingiani A, Raspagliesi F, De Braud F, Pruneri G. Conca E, et al. Among authors: tamborini e. Front Oncol. 2025 Aug 6;15:1633410. doi: 10.3389/fonc.2025.1633410. eCollection 2025. Front Oncol. 2025. PMID: 40842600 Free PMC article.
179 results